Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial

- Yassi, Nawaf, Zhao, Henry, Jeng, Jiann-Shing, Choi, Philip M. C., Duc, Phuc Dang, Brown, Helen, Ranta, Annemarei, Spratt, Neil, Cloud, Geoffrey C., Wang, Hao-Kuang, Grimley, Rohan, Mahawish, Karim, Churilov, Leonid, Cho, Der-Yang, Shah, D, Nguyen, TMP, Sharma, G, Yogendrakumar, V, Yan, B, Harrison, EL, Devlin, M, Cordato, D, Martinez-Majander, N, Wu, Teddy Y., Strbian, D, Thijs, V, Sanders, LM, Anderson, D, Parsons, MW, Campbell, BCV, Donnan, GA, Davis, SM, Ma, Henry, Nguyen, Huy-Thang, Cheung, Andrew, Meretoja, Atte, Mai, Duy Ton, Kleinig, Timothy

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

- Meretoja, Atte, Yassi, Nawaf, Wu, Teddy Y., Churilov, Leonid, Sibolt, Gerli, Jeng, Jiann-Shing, Kleinig, Timothy, Spratt, Neil J., Thijs, Vincent, Wijeratne, Tissa, Cho, Der-Yang, Shah, Darshan, Cloud, Geoffrey C., Phan, Thanh, Bladin, Christopher, Moey, Andrew, Aviv, Richard I., Barras, Christen D., Sharma, Gagan, Hsu, Chung Y., Levi, Christopher, Ma, Henry, Campbell, BCV, Mitchell, P, Yan, B, Parsons, MW, Tiainen, M, Curtze, S, Strbian, D, Tang, SC, Harvey, J, Donnan, GA, Davis, SM